Introduction {#S1}
============

A notable feature of the SARS-CoV-2 coronavirus is that its spike glycoprotein contains a polybasic furin cleavage site at the S1-S2 boundary ([@B2]; [@B12]). Furin is a protease ubiquitously expressed in multiple organs and tissues in humans, such as the brain, lung, gastrointestinal tract, liver, pancreas, and reproductive tissues ([@B13]). Cleavage of the spike protein by the furin protease is considered to facilitate the entrance of SARS-CoV-2 into host cells. Due to the wide expression of furin in multiple tissues, the existence of the furin cleavage site in the spike glycoprotein may expand tropism and enhance the transmissibility of SARS-CoV-2 ([@B12]).

When the discovery of the furin cleavage site was published on April 16, 2020 ([@B12]), there only existed 144 SARS-CoV-2 genome sequences in the GISAID database ([@B6]; [@B9]) and the furin cleavage site was strictly conserved ([@B12]). As of June 13, 2020, the number of SARS-CoV-2 genome sequences in the GISAID database has significantly increased to 45828. Therefore, we sought to answer a straightforward yet important question: are there any natural polymorphisms in the furin cleavage site of the SARS-CoV-2 spike glycoprotein? The existence of natural polymorphisms in the furin cleavage site may represent a new subgroup of SARS-CoV-2 coronavirus with different tropism and transmissibility.

Methods {#S2}
=======

In total, 45828 SARS-CoV-2 genome sequences were downloaded from the GISAID database on June 13, 2020. The microbial genomics mutation tracker (MicroGMT) software, recently published by our group ([@B15]), was applied with default parameters to identify DNA mutations between each downloaded database sequence and the reference genome sequence of SARS-CoV-2 (i.e., SARA-CoV-2 isolate Wuhan-Hu-1 complete genome sequence with GenBank accession number [NC_045512](NC_045512)) ([@B14]). In brief, MicoGMT invokes (1) minimap2 ([@B8]) to perform genome-wide pairwise alignments and (2) snpEff ([@B3]) to identify point mutations (synonymous and non-synonymous), insertions or deletions, and gains of stop codons from the genome alignments. The computation was performed for about 40 h in the high-performance research computer Ada at Texas A&M University. The NCBI Structure program^[1](#footnote1){ref-type="fn"}^ was used to characterize the changes of the biochemical properties of non-synonymous mutations.

Results {#S3}
=======

From 45828 SARS-CoV-2 genome sequences available in the GISAID database as of June 13, 2020, 103 strains of SARS-CoV-2 carried various DNA mutations including 25 unique ones that may affect the furin cleavage site located at the amino acid residual positions 680--689 (S1/S2 region) ([@B4]; [@B13]; [@B16]) of the SARS-CoV-2 spike protein ([Figure 1](#F1){ref-type="fig"}, [Table 1](#T1){ref-type="table"}, and [Supplementary Table 1](#TS1){ref-type="supplementary-material"}). Specifically, 96 SARS-CoV-2 strains were identified to carry a total of 23 unique point mutations in the furin cleavage site (each mutant strain carried only one non-synonymous point mutation in the furin cleavage site). Out of those 96 strains, 74 carried non-synonymous point mutations; out of the 23 unique point mutations, 18 were non-synonymous. Of those 18 non-synonymous changes, one changed from a non-polar amino acid residue (Ala) to a negatively charged residue (Glu); four changed from non-polar to neutral polar (Pro to Ser, Ala to Thr, and Ala to Ser at two different sites); one changed from non-polar (Pro) to positively charged (His); four changed from neutral polar to non-polar (Ser to Phe, Pro, Gly or Ile); two changed from positively charged to non-polar (Arg to Trp or Pro); two changed from positively charged to neutral polar (Arg to Gln at two different sites). Out of all the amino acid residues in the furin cleavage site, only Arg685 had no point mutations (neither synonymous nor non-synonymous). Besides point mutations, one strain (HongKong/XM-PII-S4/2020) contained a deletion in the furin cleavage site. The deletion spanned from Asn679 to Ala688, which is almost the entire length of the furin cleavage site (except for the last amino acid residue). In addition, we found six SARS-CoV-2 strains with the gains of stop codons in the spike protein between the position 258 and 516, which would abolish the downstream furin cleavage site located at the positions 680-689.

![Naturally occurring polymorphisms in the furin cleavage site of the SARS-CoV-2 spike glycoprotein. The colored bar represents the spike glycoprotein, with the blue boxes indicating the S1 and S2 subunits, green box indicating the receptor binding domain, and the arrow indicating the furin cleavage site. The positions of the six gains of premature stop codons were illustrated on the top of the color bar (^∗^ indicates the stop codon). The yellow shade on the peptide sequences indicate the furin cleavage site, and red shades indicate mutations. The multiple sequence alignment shows each identified non-synonymous mutation with the yellow background indicating the furin cleavage site from the position 680 to 689.](fgene-11-00783-g001){#F1}

###### 

Summary of mutations identified in the furin cleavage site.

  Mutation           Type                 Region                                Biochemical property                      Number of strains
  ------------------ -------------------- ------------------------------------- ----------------------------------------- -------------------
  Ser680Phe          Non-synonymous       North America                         Polar but neutral to non-polar            1
  Ser680Pro          Non-synonymous       North America                         Polar but neutral to non-polar            1
  Pro681His          Non-synonymous       Europe, North America                 Non-polar to positively charged           3
  Pro681Leu          Non-synonymous       Europe, North America                 Both non-polar                            23
  Pro681Pro          Synonymous           Europe                                N/A                                       4
  Pro681Ser          Non-synonymous       Europe, Oceania                       Non-polar to polar but neutral            5
  Arg682Arg          Synonymous           Africa, Asia, Europe, North America   N/A                                       9
  Arg682Gln          Non-synonymous       Asia, North America                   Positively charged to polar but neutral   3
  Arg682Trp          Non-synonymous       Asia, Europe, North America           Positively charged to non-polar           3
  Arg683Arg          Synonymous           Asia, Europe                          N/A                                       7
  Arg683Gln          Non-synonymous       Europe                                Positively charged to polar but neutral   2
  Arg683Pro          Non-synonymous       Europe                                Positively charged to non-polar           1
  Ala684Ala          Synonymous           Asia                                  N/A                                       1
  Ala684Glu          Non-synonymous       Asia                                  Non-polar to negatively charged           1
  Ala684Ser          Non-synonymous       North America                         Non-polar to polar but neutral            1
  Ala684Thr          Non-synonymous       Europe, North America                 Non-polar to polar but neutral            2
  Ala684Val          Non-synonymous       Europe, South America                 Both non-polar                            7
  Ser686Gly          Non-synonymous       Europe                                Polar but neutral to non-polar            1
  Ser686Ser          Synonymous           North America                         N/A                                       1
  Val687Ile          Non-synonymous       Europe                                Both non-polar                            1
  Ala688Ser          Non-synonymous       Europe                                Non-polar to polar but neutral            3
  Ala688Val          Non-synonymous       Europe                                Both non-polar                            11
  Ser689Ile          Non-synonymous       Europe                                Polar but neutral to non-polar            5
  Asn679_Ala688del   Deletion             Asia                                  N/A                                       1
  Trp258\*           Gain of stop codon   Asia                                  N/A                                       1
  Gln271\*           Gain of stop codon   Oceania                               N/A                                       1
  Arg408\*           Gain of stop codon   Europe                                N/A                                       1
  Gln414\*           Gain of stop codon   Oceania                               N/A                                       1
  Cys432\*           Gain of stop codon   Asia                                  N/A                                       1
  Glu516\*           Gain of stop codon   Asia                                  N/A                                       1

\* means stop codon.

The identified mutations in the furin cleavage site appeared in multiple geographic regions (Asia, Europe, North America, and Oceania) through January to May 2020. Most of them appeared in one or two geographic regions, but Arg682Trp appeared in three regions. Europe and North America had the most point mutations in the furin cleavage site. The only deletion was observed in Asia, and the gain of stop codons were observed in Asia, Europe, and Oceania.

Discussion {#S4}
==========

We uncovered 103 SARS-CoV-2 strains from multiple geographic regions, 81 of which carried 25 unique mutations that may affect the furin cleavage site in the spike glycoprotein. Out of the total 10 amino acid residues in the furin cleavage site, nine experienced non-synonymous changes. It is worth noting that the non-synonymous point mutations occurred at seven out of eight amino acid residues of the highly conserved region of 682 RRARSVAS689 ([@B1]). This conserved region included three of the four amino acid residues of 681PRRA684 that are unique to SARS-CoV-2 ([@B16]) (non-synonymous point mutations also occurred at Pro681), containing the furin cleavage point between Arg685 and Ser686 ([@B4]). Although no mutations were identified at Arg685, mutations existed at Ser686 (e.g., Gly) disabling furin-type cleavages. In addition, mutations around Arg685 and Ser686 may also affect the recognition of the cleavage site. Point mutations and deletions were also found upstream and downstream of positions 680-689 including two deletions from position 675--679 (data not shown). Finally, we also observed one deletion and six gains of premature stop codons, all of which completely abrogated the furin cleavage site. Interestingly, [@B5] also detected one deletion in the furin cleavage site based on RNA-Seq sequencing.

Since all the mutations were identified from live viral strains in COVID-19 patients, our results revealed that the furin cleavage site may not be required for SARS-CoV-2 to enter human cells *in vivo*, which agrees with the *in vitro* experimental results showing that SARS-CoV-2, with deletion of the furin cleavage site, could still enter the cell lines of humans, African green monkeys, and bay hamsters ([@B12]). Therefore, we speculate that our observed mutants may represent a new subgroup of SARS-CoV-2 coronavirus with reduced tropism and transmissibility, which requires further experimental validations. Analyzing clinical symptoms and infectiousness of the COVID-19 patients with those mutant strains may be also important in future studies. If tropism and transmissibility of those mutant strains were indeed reduced, they might serve as potential live-attenuated vaccine candidates ([@B11]; [@B7]; [@B10]).
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